144 related articles for article (PubMed ID: 12102632)
21. Kinds of mutations formed when a shuttle vector containing adducts of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9, 10-tetrahydrobenzo[a]pyrene replicates in human cells.
Yang JL; Maher VM; McCormick JJ
Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3787-91. PubMed ID: 3108878
[TBL] [Abstract][Full Text] [Related]
22. Ability of adducts formed in a shuttle vector by reactive metabolites of 1-nitropyrene and benzo(a)pyrene to induce mutations when the plasmid replicates in human cells.
Maher VM; Yang JL; McCormick JJ
Acta Biol Hung; 1990; 41(1-3):173-86. PubMed ID: 2128787
[TBL] [Abstract][Full Text] [Related]
23. Rat, but not human, sulfotransferase activates a tamoxifen metabolite to produce DNA adducts and gene mutations in bacteria and mammalian cells in culture.
Glatt H; Davis W; Meinl W; Hermersdörfer H; Venitt S; Phillips DH
Carcinogenesis; 1998 Oct; 19(10):1709-13. PubMed ID: 9806149
[TBL] [Abstract][Full Text] [Related]
24. DNA adduct formation and mutant induction in Sprague-Dawley rats treated with tamoxifen and its derivatives.
Gamboa da Costa G; McDaniel-Hamilton LP; Heflich RH; Marques MM; Beland FA
Carcinogenesis; 2001 Aug; 22(8):1307-15. PubMed ID: 11470763
[TBL] [Abstract][Full Text] [Related]
25. The mutational signature of alpha-hydroxytamoxifen at Hprt locus in Chinese hamster cells.
Yadollahi-Farsani M; Davies DS; Boobis AR
Carcinogenesis; 2002 Nov; 23(11):1947-52. PubMed ID: 12419845
[TBL] [Abstract][Full Text] [Related]
26. Quinol-glutathione conjugate-induced mutation spectra in the supF gene replicated in human AD293 cells and bacterial MBL50 cells.
Jeong JK; Wogan GN; Lau SS; Monks TJ
Cancer Res; 1999 Aug; 59(15):3641-5. PubMed ID: 10446975
[TBL] [Abstract][Full Text] [Related]
27. Identification and quantification of tamoxifen-DNA adducts in the liver of rats and mice.
Umemoto A; Komaki K; Monden Y; Suwa M; Kanno Y; Kitagawa M; Suzuki M; Lin CX; Ueyama Y; Momen MA; Ravindernath A; Shibutani S
Chem Res Toxicol; 2001 Aug; 14(8):1006-13. PubMed ID: 11511174
[TBL] [Abstract][Full Text] [Related]
28. Genotoxicity and mutagenicity of the alpha, beta-unsaturated carbonyl compound crotonaldehyde (butenal) on a plasmid shuttle vector.
Czerny C; Eder E; Rünger TM
Mutat Res; 1998 Mar; 407(2):125-34. PubMed ID: 9637241
[TBL] [Abstract][Full Text] [Related]
29. Identification of tamoxifen-DNA adducts formed by 4-hydroxytamoxifen quinone methide.
Marques MM; Beland FA
Carcinogenesis; 1997 Oct; 18(10):1949-54. PubMed ID: 9364005
[TBL] [Abstract][Full Text] [Related]
30. Effects of peroxynitrite dose and dose rate on DNA damage and mutation in the supF shuttle vector.
Kim MY; Dong M; Dedon PC; Wogan GN
Chem Res Toxicol; 2005 Jan; 18(1):76-86. PubMed ID: 15651852
[TBL] [Abstract][Full Text] [Related]
31. Tamoxifen metabolic activation: comparison of DNA adducts formed by microsomal and chemical activation of tamoxifen and 4-hydroxytamoxifen with DNA adducts formed in vivo.
Moorthy B; Sriram P; Pathak DN; Bodell WJ; Randerath K
Cancer Res; 1996 Jan; 56(1):53-7. PubMed ID: 8548775
[TBL] [Abstract][Full Text] [Related]
32. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling.
Divi RL; Osborne MR; Hewer A; Phillips DH; Poirier MC
Cancer Res; 1999 Oct; 59(19):4829-33. PubMed ID: 10519392
[TBL] [Abstract][Full Text] [Related]
33. DNA damage and mutations produced by chloroacetaldehyde in a CpG-methylated target gene.
Choi JH; Pfeifer GP
Mutat Res; 2004 Dec; 568(2):245-56. PubMed ID: 15542111
[TBL] [Abstract][Full Text] [Related]
34. Minor products of reaction of DNA with alpha-acetoxytamoxifen.
Osborne MR; Hardcastle IR; Phillips DH
Carcinogenesis; 1997 Mar; 18(3):539-43. PubMed ID: 9067554
[TBL] [Abstract][Full Text] [Related]
35. Identification of hepatic tamoxifen-DNA adducts in mice: alpha-(N(2)-deoxyguanosinyl)tamoxifen and alpha-(N(2)-deoxyguanosinyl)tamoxifen N-oxide.
Umemoto A; Monden Y; Suwa M; Kanno Y; Suzuki M; Lin CX; Ueyama Y; Momen MA; Ravindernath A; Shibutani S; Komaki K
Carcinogenesis; 2000 Sep; 21(9):1737-44. PubMed ID: 10964106
[TBL] [Abstract][Full Text] [Related]
36. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis.
Zhitkovich A; Song Y; Quievryn G; Voitkun V
Biochemistry; 2001 Jan; 40(2):549-60. PubMed ID: 11148050
[TBL] [Abstract][Full Text] [Related]
37. AlkB influences the chloroacetaldehyde-induced mutation spectra and toxicity in the pSP189 supF shuttle vector.
Kim MY; Zhou X; Delaney JC; Taghizadeh K; Dedon PC; Essigmann JM; Wogan GN
Chem Res Toxicol; 2007 Aug; 20(8):1075-83. PubMed ID: 17658757
[TBL] [Abstract][Full Text] [Related]
38. Further characterization of the DNA adducts formed in rat liver after the administration of tamoxifen, N-desmethyltamoxifen or N, N-didesmethyltamoxifen.
Brown K; Heydon RT; Jukes R; White IN; Martin EA
Carcinogenesis; 1999 Oct; 20(10):2011-6. PubMed ID: 10506118
[TBL] [Abstract][Full Text] [Related]
39. Identification of the major tamoxifen-deoxyguanosine adduct formed in the liver DNA of rats treated with tamoxifen.
Osborne MR; Hewer A; Hardcastle IR; Carmichael PL; Phillips DH
Cancer Res; 1996 Jan; 56(1):66-71. PubMed ID: 8548777
[TBL] [Abstract][Full Text] [Related]
40. Mutations induced in a shuttle vector plasmid exposed to monofunctionally activated mitomycin C.
Maccubbin AE; Mudipalli A; Nadadur SS; Ersing N; Gurtoo HL
Environ Mol Mutagen; 1997; 29(2):143-51. PubMed ID: 9118966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
